hTERT Human Lung Cancer-Associated Fibroblasts (CAF) – Squamous Cell Carcinoma

$6,000.00

Catalog Number: HT14
Product Format: Frozen Vial
Cell Number: 1,000,000 cells/vial
Suggested Medium: CAF Growth Medium


General Information

Puromycin-resistant hTERT fibroblasts were selected from HLCCAF following lentiviral transduction of hTERT.
These Human Lung CAFs, derived from squamous cell carcinoma tissue, were cultured in T75 tissue culture flasks pre-coated with AlphaBioCoat and incubated in CAF Growth Medium for 3–7 days. At passage 1, cells were cryopreserved and stored frozen. Each vial contains ≥1,000,000 viable cells.


Product Testing

  • Negative for: von Willebrand Factor/Factor VIII, cytokeratin 18, and alpha-smooth muscle actin

  • Mycoplasma, bacteria, yeast, fungi: Not detected

  • CAF Marker Expression: FAP, PDGFR, Vimentin, PDPN, CD70

  • Expansion Capacity: 3–5 passages at a 1:2 or 1:3 split ratio


Laboratory Applications

  • Tumor microenvironment modeling

  • Cell-cell interaction assays

  • Western blotting, PCR, immunoprecipitation

  • Flow cytometry and immunofluorescence

  • Custom CAF-based lung cancer models


Shipping

Frozen vials shipped on dry ice


Post-Thaw Recovery Protocol

  1. Thawing & Aseptic Handling

    • Thaw the cryovial by gently agitating in a 37°C water bath (~2 minutes).

    • Do not submerge the cap.

    • Decontaminate the vial by spraying or dipping in 70% ethanol.

    • Proceed under strict aseptic conditions.

  2. Cell Recovery & Seeding

    • Centrifuge at 125 × g for 5–10 minutes.

    • Discard the supernatant and resuspend in fresh CAF Growth Medium.

    • Coat a T-flask with 6–8 mL AlphaBioCoat (15 minutes), rinse with 8 mL 1× PBS, discard.

    • Plate cells in the prepared flask.

  3. Incubation Conditions

    • Incubate at 37°C in a humidified 5% CO₂ incubator.

    • Pre-equilibrate the growth medium in the incubator for 15 minutes to ensure a pH of 7.0–7.6.


Subculturing Instructions

Volumes below are for 75 cm² flasks. Adjust for other formats accordingly.

  1. Remove spent medium.

  2. Rinse with 1× PBS to eliminate residual serum inhibitors.

  3. Add 2.0–3.0 mL Cell Detachment Solution. Incubate 5–15 minutes at 37°C.

    • Do not agitate the flask to avoid clumping.

    • Warm flask or extend incubation if detachment is incomplete.

  4. Coat a new flask with AlphaBioCoat (6–8 mL for 15 minutes), rinse with 8 mL PBS, discard.

  5. Resuspend cells in 6.0–8.0 mL of complete growth medium.

  6. Plate appropriate aliquots into new flasks.

  • Subcultivation Ratio: 1:2 to 1:3

  • Medium Renewal: Every 3 to 4 days


Cryopreservation Protocol

  • Use complete growth medium supplemented with 5% (v/v) DMSO

  • Cryopreservation Medium Catalog #: CGM5

  • Freeze in isopropanol containers at –80°C overnight, then transfer to liquid nitrogen


Product Usage

Cells are offered for Research Use Only. Not for Clinical Use.

Benefits

Maximizes Cell Viability & Recovery

Preserves Phenotype & Biomarker Expression

hTERT Human Lung Cancer-Associated Fibroblasts (CAF) – Squamous Cell Carcinoma

Scientifically engineered formulations, optimized for maximum cellular performance and validated through rigorous quality control.

Optimized for cellular viability and function

Engineered to support robust cell health, proliferation, and performance across passages.

Formulated for consistency and reproducibility

Minimizes variability to ensure reliable outcomes in every experiment.

Validated for purity, sterility, and performance

Extensively tested to meet rigorous quality, safety, and regulatory standards.

Stabilized

Broad cell line compatibility

Scientifically validated

Nutrient-optimized

Consistency you can trust. Each formulation is optimized to deliver reliable outcomes across experiments and timepoints.

Pairs well with